CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
Phase 2
Budapest, Hungary and 84 other locations
This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).
Phase 2
Budapest, Hungary and 104 other locations
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Phase 3
Budapest, Hungary and 555 other locations
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description
Phase 3
Budapest, Hungary and 342 other locations
Clinical trials
Research sites
Resources
Legal